IGM Biosciences, Inc. Financing Cash Flow
IGM Biosciences, Inc. reported Financing Cash Flow of $17.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-07-31
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $12.00K, a 98.05% decline year-over-year.
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $5.00K, a 96.71% decline year-over-year.
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was $420.00K, a 4.48% increase year-over-year.
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $1.20M, a 97.31% decline year-over-year.
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $2.39M, a 97.92% decline from fiscal 2023.
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $115.07M, a 47.55% decline from fiscal 2022.
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $219.38M, a 8760.34% increase from fiscal 2021.
- IGM Biosciences, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $2.48M, a 98.85% decline from fiscal 2020.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $17.00K 10-Q · filed 2025-07-31 | $437.00K derived: sum of 3 quarters · filed 2025-07-31 | $1.64M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2025-03-31 | $5.00K 10-Q · filed 2025-05-13 | $425.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.63M derived: sum of 3 quarters · filed 2025-05-13 | $2.24M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.62M derived: sum of 2 quarters · filed 2025-03-06 | $2.24M derived: sum of 3 quarters · filed 2025-07-31 | $2.39M 10-K · filed 2025-03-06 | |
| 2024-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.82M derived: sum of 2 quarters · filed 2025-07-31 | $1.97M 10-Q · filed 2024-11-08 | $2.37M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-06-30 | $615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $767.00K 10-Q · filed 2025-07-31 | $1.17M derived: sum of 3 quarters · filed 2025-07-31 | $45.81M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $152.00K 10-Q · filed 2025-05-13 | $554.00K derived: sum of 2 quarters · filed 2025-05-13 | $45.19M derived: sum of 3 quarters · filed 2025-05-13 | $115.14M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | $402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $45.04M derived: sum of 2 quarters · filed 2025-03-06 | $114.99M derived: sum of 3 quarters · filed 2025-03-06 | $115.07M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $44.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $114.59M derived: sum of 2 quarters · filed 2024-11-08 | $114.67M 10-Q · filed 2024-11-08 | $115.15M derived: sum of 4 quarters · filed 2025-03-06 | |
| 2023-06-30 | $69.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $70.03M 10-Q · filed 2024-08-14 | $70.51M derived: sum of 3 quarters · filed 2025-03-06 | $70.81M derived: sum of 4 quarters · filed 2025-03-06 | |
| 2023-03-31 | $75.00K 10-Q · filed 2024-05-08 | $557.00K derived: sum of 2 quarters · filed 2025-03-06 | $854.00K derived: sum of 3 quarters · filed 2025-03-06 | $219.38M derived: sum of 4 quarters · filed 2025-03-06 | |
| 2022-12-31 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $779.00K derived: sum of 2 quarters · filed 2025-03-06 | $219.31M derived: sum of 3 quarters · filed 2025-03-06 | $219.38M 10-K · filed 2025-03-06 | |
| 2022-09-30 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $218.83M derived: sum of 2 quarters · filed 2023-11-13 | $218.90M 10-Q · filed 2023-11-13 | $220.39M derived: sum of 4 quarters · filed 2024-03-07 | |
| 2022-06-30 | $218.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $218.60M 10-Q · filed 2023-08-03 | $220.09M derived: sum of 3 quarters · filed 2024-03-07 | $221.16M derived: sum of 4 quarters · filed 2024-03-07 | |
| 2022-03-31 | $72.00K 10-Q · filed 2023-05-12 | $1.56M derived: sum of 2 quarters · filed 2024-03-07 | $2.63M derived: sum of 3 quarters · filed 2024-03-07 | $2.60M derived: sum of 4 quarters · filed 2024-03-07 | |
| 2021-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.56M derived: sum of 2 quarters · filed 2024-03-07 | $2.53M derived: sum of 3 quarters · filed 2024-03-07 | $2.48M 10-K · filed 2024-03-07 | |
| 2021-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.04M derived: sum of 2 quarters · filed 2022-11-03 | $985.00K 10-Q · filed 2022-11-03 | -$985.00K 10-Q · filed 2021-11-04 | $216.90M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$86.00K 10-Q · filed 2022-08-08 | $215.82M derived: sum of 3 quarters · filed 2023-03-30 | $214.91M derived: sum of 4 quarters · filed 2023-03-30 | |
| 2021-03-31 | -$53.00K 10-Q · filed 2022-05-09 | $215.86M derived: sum of 2 quarters · filed 2023-03-30 | $214.94M derived: sum of 3 quarters · filed 2023-03-30 | $214.71M derived: sum of 4 quarters · filed 2023-03-30 | |
| 2020-12-31 | $215.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $214.99M derived: sum of 2 quarters · filed 2023-03-30 | $214.76M derived: sum of 3 quarters · filed 2023-03-30 | $214.78M 10-K · filed 2023-03-30 | |
| 2020-09-30 | -$917.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$1.15M derived: sum of 2 quarters · filed 2021-11-04 | -$1.13M 10-Q · filed 2021-11-04 | -$3.12M derived: sum of 4 quarters · filed 2022-03-29 | |
| 2020-06-30 | -$234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$212.00K 10-Q · filed 2021-08-09 | -$2.21M derived: sum of 3 quarters · filed 2022-03-29 | $222.44M derived: sum of 4 quarters · filed 2022-03-29 | |
| 2020-03-31 | $22.00K 10-Q · filed 2021-05-06 | -$1.97M derived: sum of 2 quarters · filed 2022-03-29 | $222.68M derived: sum of 3 quarters · filed 2022-03-29 | $272.25M derived: sum of 4 quarters · filed 2022-03-29 | |
| 2019-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $222.66M derived: sum of 2 quarters · filed 2022-03-29 | $272.23M derived: sum of 3 quarters · filed 2022-03-29 | $282.26M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $224.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $274.22M derived: sum of 2 quarters · filed 2020-11-05 | $284.25M 10-Q · filed 2020-11-05 | $289.49M derived: sum of 4 quarters · filed 2021-03-30 | |
| 2019-06-30 | $49.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $59.60M 10-Q · filed 2020-08-06 | $64.84M derived: sum of 3 quarters · filed 2021-03-30 | ||
| 2019-03-31 | $10.03M 10-Q · filed 2020-05-07 | $15.27M derived: sum of 2 quarters · filed 2021-03-30 | |||
| 2018-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $22.34M 10-K · filed 2021-03-30 | |||
| 2018-09-30 | $17.10M 10-Q · filed 2019-11-07 | ||||
| 2017-12-31 | $8.07M 10-K · filed 2020-03-26 |